EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Severe steroid‐related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy—An observational Ponte di Legno Toxicity Working Group Study

Stavroula Anastasopoulou iD, Gemma Swann, Liv Andres-Jensen, Andishe Attarbaschi iD, Shlomit Barzilai-Birenboim, Daniel J Erdelyi, Gabriele Escherich iD, Lina Hamadeh, Arja Harila, Elixabet Lopez-Lopez iD, Sheena McGowan, Anja Möricke und 13 weitere

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19610 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Stavroula Anastasopoulou und 24 weiteren Autor:innen. Beteiligte Einrichtung: Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Neurotoxicity Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Steroids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Childhood Cancer Fund (Barncancerfonden), Children with Cancer UK, Schiehallion Childrens Cancer and Leukaemia Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Steroids are a mainstay in the treatment of acute lymphoblastic leukaemia (ALL) in children and adolescents; however, their use can cause clinically significant steroid‐related neuropsychiatric symptoms (SRNS). As current knowledge on SRNS during ALL treatment is limited, we mapped the phenotypes, occurrence and treatment strategies using a database created by the international Ponte di Legno Neurotoxicity Working Group including data on toxicity in the central nervous system (CNS) in patients treated with frontline ALL protocols between 2000 and 2017. Ninety‐four of 1813 patients in the CNS toxicity database (5.2%) experienced clinically significant SRNS with two peaks: one during induction and one during intensification phase. Dexamethasone was implicated in 86% of SRNS episodes. The most common symptoms were psychosis (52%), agitation (44%) and aggression (31%). Pharmacological treatment, mainly antipsychotics and benzodiazepines, was given to 87% of patients while 38% were hospitalised due to their symptoms. Recurrence of symptoms was reported in 29% of patients and two previously healthy patients required ongoing pharmacological treatment at the last follow up. Awareness of SRNS during ALL treatment and recommendation on treatment strategies merit further studies and consensus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurotoxicity SyndromesPrecursor Cell Lymphoblastic Leukemia-LymphomaSteroidsAdolescentChildChild, PreschoolFemaleHumansInfantMaleAntineoplastic Combined Chemotherapy ProtocolsDexamethasone

Stichwörter der Autor:innen

ALLchildrenneuropsychiatric symptomssteroids

Substanzen

DexamethasoneSteroids

Autor:innen und Institutionen

  • Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland.
  • Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Copenhagen, Denmark.
  • Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
  • St. Anna Children's Cancer Research Institute, Vienna, Austria.

ORCID-Profile: Stavroula Anastasopoulou, Andishe Attarbaschi, Gabriele Escherich, Elixabet Lopez-Lopez, Inge M van der Sluis, Deepa Bhojwani, Christina Halsey

Förderung

  • Swedish Childhood Cancer Fund (Barncancerfonden)
  • Children with Cancer UK
  • Schiehallion Childrens Cancer and Leukaemia Fund
  • Cancer Research UK (Programme Foundation Award)
  • Glasgow Children's Hospital Charity
  • MH CZ - DRO Motol University Hospital, Prague, Czech Republic
  • CRUK Scotland Centre
  • Barncancerfonden

Zitieren

APA

Anastasopoulou, S., Swann, G., Andres-Jensen, L., Attarbaschi, A., Barzilai-Birenboim, S., Erdelyi, D. J., Escherich, G., Hamadeh, L., Harila, A., Lopez-Lopez, E., McGowan, S., Möricke, A., Putti, C., Sagi, J. C., Schmiegelow, K., Ullrich, N. J., van der Sluis, I. M., Wahid, Q. U., Winick, N., …, & Ponte Di Legno Neurotoxicity Working Group (2024). Severe steroid‐related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy—An observational Ponte di Legno Toxicity Working Group Study. British Journal of Haematology. https://doi.org/10.1111/bjh.19610

Vancouver

Anastasopoulou S, Swann G, Andres-Jensen L, Attarbaschi A, Barzilai-Birenboim S, Erdelyi DJ, et al. Severe steroid‐related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy—An observational Ponte di Legno Toxicity Working Group Study. British Journal of Haematology. 2024. doi:10.1111/bjh.19610

BibTeX
@article{Anastasopoulou2024,
  author = {Anastasopoulou, Stavroula and Swann, Gemma and Andres-Jensen, Liv and Attarbaschi, Andishe and Barzilai-Birenboim, Shlomit and Erdelyi, Daniel J and Escherich, Gabriele and Hamadeh, Lina and Harila, Arja and Lopez-Lopez, Elixabet and McGowan, Sheena and Möricke, Anja and Putti, Caterina and Sagi, Judit C and Schmiegelow, Kjeld and Ullrich, Nicole J and van der Sluis, Inge M and Wahid, Qurat-Ul-Ain and Winick, Naomi and Sramkova, Lucie and Zalcberg, Yair and Zapotocka, Ester and Bhojwani, Deepa and Halsey, Christina and Ponte Di Legno Neurotoxicity Working Group, Ponte Di Legno Neurotoxicity Working Group},
  title = {Severe steroid‐related neuropsychiatric symptoms during paediatric acute lymphoblastic leukaemia therapy—An observational Ponte di Legno Toxicity Working Group Study},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19610}
}
Kostenlos starten →